hemoglobin and red cell structure and function978-1-4684-3222-0/1.pdfred cell structure and function...
TRANSCRIPT
HEMOGLOBIN AND RED CELL STRUCTURE AND FUNCTION
ADV ANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY Editorial Board:
Nathan Back
N. R. Di Luzio
Alfred Gellhorn
Bernard Halpern
Ephraim Katchalski
David Kritchevsky
Abel Lajtha
Rodolfo Paoletti
Volume 1
Chairman, Department of Biochemical Pharmacology, School of Pharmacy, State University of New York, Buffalo, New York
Chairman, Department of Physiology, . Tulane University School of Medicine, New Orleans, Louisiana
University of Pennsylvania Medical School, Philadelphia, Pennsylvania
College de France, Director of the Institute of Immuno.Biology, Paris, France
Department of Biophysics, The Weizmann Institute of Science, Rehovoth. Israel
Wistar Institute, Philadelphia, Pennsylvania
New York State Research Institute for Neurochemistry and Drug Addiction, Ward's Island, New York
Institute of Pharmacology, University of Milan, Milan,Italy
THE RETICULOENDOTHELIAL SYSTEM AND ATHEROSCLEROSIS Edited by N. R. Di Luzio and R. Paoletti· 1967
Volume 2 PHARMACOLOGY OF HORMONAL POLYPEPTIDES AND PROTEINS
Edited by N. Back, L. Martini, and R. Paoletti· 1968
Volume 3 GERM·FREE BIOLOGY: Experimental and Clinical Aspects
Edited by E. A. Mirand and N. Back· 1969
Volume 4 DRUGS AFFECTING LIPID METABOLISM
Edited by W. L. Holmes, L. A. Carlson, and R. Paoletti· 1969
Volume 5 LYMPHATIC TISSUE AND GERMINAL CENTERS IN IMMUNE RESPONSE
Edited by L. Fiore·Donati and M. G. Hanna, Jr .• 1969
Volume 6 RED CELL METABOLISM AND FUNCTION
Edited by George J. Brewer· 1970
Volume 7 SURFACE CHEMISTRY OF BIOLOGICAL SYSTEMS
Edited by Martin Blank· 1970
Volume 8 BRADYKININ AND RELATED KININS: Cardiovascular, Biochemical, and Neural Actions
Edited by F. Sicuteri, M. Rocha e Silva, and N. Back· 1970
Volume 9 SHOCK: Biochemical, Pharmacological, and Clinical Aspects
Edited by A. Bertelli and N. Back· 1970
Volume 10 THE HUMAN TESTIS
Edited by E. Rosemberg and C. A. Paulsen· 1970
Volume 11 MUSCLE METABOLISM DURING EXERCISE
Edited by B. Pemow and B. Sahin· 1971
Volume 12 MORPHOLOGICAL AND FUNCTIONAL ASPECTS OF IMMUNITY
Edited by K. Lindahl.Kiessling, G. AIm, and M. G. Hanna, Jr.· 1971
Volume 13 CHEMISTRY AND BRAIN DEVELOPMENT
Edited by R. Paoletti and A. N. Davison· 1971
Volume 14 MEMBRANE·BOUND ENZYMES
Edited by G. Porcellati and F. di Jeso • 1971
Volume 15 THE RETICULOENDOTHELIAL SYSTEM AND IMMUNE PHENOMENA
Edited by N. R. Di Luzio and K. Flemming· 1971
Volume 16A THE ARTERY AND THE PROCESS OF ARTERIOSCLEROSIS: Pathogenesis
Edited by Stewart W oU • 1971
Volume 16B THE ARTERY AND THE PROCESS OF ARTERIOSCLEROSIS: Measurement and Modification
Edited by Stewart Wolf· 1971
Volume 17 CONTROL OF RENIN SECRETION
Edited by Tatiana A. Assaykeen • 1972
Volume 18 THE DYNAMICS OF MERISTEM CELL POPULATIONS
Edited by Morton W. Miller and Charles C. Kuehnert • 1972
Volume 19 SPHINGOLIPIDS, SPHINGOLIPIDOSES AND ALLIED DISORDERS
Edited by Bruno W. Volk and Stanley M. Aronson. 1972
Volume 20 DRUG ABUSE: Nonmedical Use of Dependence-Producing Drugs
Edited by Simon Btesh • 1972
Volume 21 VASOACTIVE POLYPEPTIDES
Edited by N. Back and F. Sicuteri • 1972
Volume 22 COMPARATIVE PATHOPHYSIOLOGY OF CIRCULATORY DISTURBANCES
Edited by Colin M. Bloor • 1972
Volume 23 THE FUNDAMENTAL MECHANISMS OF SHOCK
Edited by Lerner B. Hinshaw and Barbara G. Cox. 1972
Volume 24 THE VISUAL SYSTEM: Neurophysiology, Biophysics, and Their Clinical Applications
Edited by G. B. Arden. 1972
Volume 25 GLYCOLIPIDS, GLYCOPROTEINS, AND MUCOPOLYSACCHARIDES OF THE NERVOUS SYSTEM
Edited by Vittorio Zambotti, Guido Tettamanti, and Mariagrazia Arrigoni. 1972
Volume 26 PHARMACOLOGICAL CONTROL OF LIPID METABOLISM
Edited by William L. Holmes, Rodolfo Paoletti, and David Kritchevsky • 1972
Volume 27 DRUGS AND FETAL DEVELOPMENT
Edited by M. A. Klingberg, A. Abramovici, and J. Chemke .1972
Volume 28 HRMOGLOBIN AND RED CELL STRUCTURE AND FUNCTION
HEMOGLOBIN AND RED CELL STRUCTURE AND FUNCTION
Proceedings of the Second International Conference on Red Cell Metabolism and Function h~ld at the University of Michigan Ann Arbor, April 27-29, 1972
Edited by
George J. Brewer Department of Human Genetics and Medicine (Simpson Memorial Institute) University of Michigan Ann Arbor, Michigan
~ PLENUM PRESS • NEW YORK - LONDON • 1972
The Second International Conference on Red Cell Metabolism and Function was sponsored in part by Office of Naval Research (Contract #NOOOI4-72-C-0338) Michigan Cancer Institute The National Foundation Abbott Laboratories
Library of Congress Catalog Card Number 72-86140
ISBN-13: 978-1-4684-3224-4 e-ISBN-13: 978-1-4684-3222-0 DOl: 10.1007/978-1-4684-3222-0
© 1972 Plenum Press, New York Softcover reprint of the hardcover 1st edition 1972 A Division of Plenum Publishing Corporation 227 West 17th Street, New York, N.Y. 10011
United Kingdom edition published by Plenum Press, London A Division of Plenum Publishing Company Davis House (4th Floor), 8 Scrubs Lane, Harlesden, London, NWIO 6SE, England
All rights reserved
No part of this publication may be reproduced in any form without written permission from the publisher
PREFACE
Hemoglobin and the red cell have continued to set a dizzying pace as the objects of research in the two and one-half year interval since the First International Conference on Red Cell Metabolism and Function. Most exciting perhaps, is a beginning molecular attack on sickle cell disease. The story of the interaction of red cell metabolism and oxygen transport has continued to unfold, and we can now infer that patients with hypoxia usually utilize red cell metabolic adjustments to improve oxygenation. This puts the red cell squarely in the center of medical practice, since much of medicine-heart, pulmonary, and blood diseases -deals with inadequate oxygenation.
On April 27th through the 29th, 1972, crystallographers, chemists, biochemists, physiologists, geneticists, and physicians from many medical disciplines met in the Towsley Center for Continuing Medical Education at the University of Michigan, Ann Arbor to present new data, to review recent developments, and to try to piece together additional features of the red cell puzzle. The meeting was dedicated to Dr. Francis John Worsley Roughton, Professor Emeritus of Colloid Science, University of Cambridge, England, in recognition of his numerous excellent contributions to the understanding of hemoglobin and red cell function.
The program got off to a good start with a paper from M. F. Perutz, Nobel Laureate, on the structure of hemoglobin. Dr. Perutz also key-noted the Conference with a special lecture on heme-heme interaction. A number of fascinating papers were presented on various aspects of hemoglobin, its structure, its interaction with ligands such as oxygen, and its properties under varying conditions. Red cell metabolism was considered, in depth, from many viewpoints, including defects in uremia, interactions with serum phosphorous, male -female differences, the role of catalase, genetic selection for quantitative variation, and
vii
viii PREFACE
mechanisms of glycolytic response to altitude stress and to anemia. As with the first conference, a session was devoted to the continuing assessment of the importance of decline in red cell oxygen transport functional capacity during blood bank storage. A session was also devoted to consideration of carbonic anhydrase and carbon dioxide transport, and the interaction of this area with oxygen transport.
A high point of the conference was the session on sickle cell structure and function. Excellent papers were presented on cyanate, including results of some early clinical trials which look promising. A trial with oral urea in sickle cell disea.se indicating possible usefulness of this approach was presented. The antis ickling properties of carbamyl phosphate were also discussed. The present status of prenatal diagnosis of sickle cell disease, and the sickling phenomenon of deer erythrocytes, we re other interesting topics. The discussions in the general area of sickle cell disease and the mechanisms by which antis ickling agents act were quite interesting because of the diversity and expertise represented in the audience.
This volume contains the Proceedings of this second conference. It includes the formal papers and much of the informal discussion after the papers. It represents a compilation of the present state of the art, and the status of current thinking, in the various areas dis cussed above.
The Editor would like to acknowledge the great dedication and assistance of Mrs. Nellie Gill in all phases of the Conference, and pUblication of the volume. My wife, Lucia Feitler Brewer, worked very hard on all aspects of Conference organization, while keeping one hand busy in the laboratory. The continued good spirits of these two in the face of ever-mounting details and problems before and during the Conference, buoyed the rest of us. I wish to thank Dr. Fred J. Oelshlegel, Jr. and Dr. John W. Eaton for their counsel. Thanks are also due Ms. Nancy Noble, Ms. Lorna Grindlay Moore, Mr. Eric Schoomaker, Mr. Conrad Knutsen, Mr. Barry Sander, Dr. James V. Neel, Dr. C.J.D. Zarafonetis, and Dean John Gronvall for their help and support. The staff of Postgraduate Medicine, in particular Mr. Jack Burmeister, Mr. Robert Richards, and Mrs. Lynne Bowbeer, we re quite helpful. Mrs. Rena J ones and Mrs. Marion Wolfe (and Mrs. Nellie Gill) dese rve much credit for struggling with the discussion tapes. Financial support from the Office of Naval Research, the National Foundation, the University of Michigan Cancer Research Institute, and Abbott Laboratories made the
PREFACE ix
Conference possible. I thank the Biochemical Journal and the Biochemical Society for us"e of the photograph of Dr. Roughton. Plenum Press published the Proceedings of the First Conference in record time, and judging from their helpfulness with this volume, I anticipate another remarkable job.
THE EDITOR
May 19, 1972
DEDICATION
OF THE SECOND INTERNATIONAL CONFERENCE ON
RED CELL METABOLISM AND FUNCTION TO
DR. FRANCIS JOHN WORSLEY ROUGHTON PROFESSOR EMERITUS OF COLLOID SCIENCE
UNIVERSITY OF CAMBRIDGE, ENGLAND
Dr. Roughton was born on June 6, 1899, in Kettering, an industrial town in the midlands of England, His Roughton ancestors were busy practicing doctors in the town for five generations - father to son - from 1737 to 1933. As a boy he hoped, in due course, to become the sixth of the series, but his physical cons titution - notably a cardiac anomaly - made such an arduous livelihood unwise. His father, the last of the five generations of Kettering doctors, urged him in 1912 ins tead to become a scientist with a special lean towards chemistry and its borders with medical sciences, for which he saw a great future. It is interesting to recall that Dr. Roughton's great grandfather William, in a letter to home in 1799 from St. Bartholomew's Hospital, London, where he was a medical student, apologized for his extravagance in spending ten shillings and sixpence (about 2 1/2 dollars at the current rate of exchange) on Lavoisier's Treatise of Chemistry, which he considered lias indispensably necessary for the understanding of the modern physiology".
In the course of his genealogical researches, to which he is almost as devoted as to his scientific work, Dr. Roughton was thrilled to discover in 1955 that he is directly descended, through his Roughton great grandmother, from Daniel Harvey, one of the brothers of William Harvey, the discoverer of the circulation of the blood. William Harvey, though married, was childless so that as one of his numerous seven great nephews, Dr.
xi
xii DEDICATION
Roughton is as closely related to the illustrious William Harvey as anyone now living.
After a conventional British schoolboy education, Dr. Roughton won an open competitive scholarship at Trinity College, Cambridge, in mathematics, physics, and chemistry. To these subjects he added at the University, biology and physiology, including biochemistry which at that time had not attained full independence. In 1920, only a few days before his 21st birthday, an accident, fortunate for him, brought him suddenly into the
front line of research. Joseph Barcroft had just published the result of a pioneer "simulated altitude" experiment in which he lived for 10 days in a glass chamber with the partial pressure of oxygen being steadily reduced to a value corresponding to an altitude of about 15,000 feet. Barcroft found no evidence of development of oxygen secretion by the lung, as his colleague, J. S. Haldane of Oxford, had claimed as an important feature of acclimatization to high altitude. Also included in the class ical paper of Barcroft et al. were calculations of the diffus ion constant of the lung which Roughton, though only a student of 20, promptly spotted as erroneous. Barcroft, 30 years older, equally promptly and generously took his very junior colleague into partnership to rectify the error, and several joint papers followed. From 1921 to 1923 Roughton not only worked on his own on the diffus ion problem, but also went into a 5 -year partnership with Hamilton Hartridge leading in the winter of 1922 to the development of the Hartridge-Roughton method for measuring the velocity of rapid reactions. These reserrches won for Roughton a competitive prize fellowship at Trinity College for 6 years (1923-1929). During this period he attained rapid promotion in Cambridge University, first as a University Lecturer in Physical Biochemistry and then (1926-1947) to a similar post (the equivalent of an Associate Professorship) in Physico-Chemical Physiology. Dr. Roughton spent much of World War II on the East Coast of the United States, helping in war science projects (a) in the Harvard Fatigue Laboratory at Boston, mainly on problems to do with ca rbon monoxide which were of considerable military importance, and (b) in the Physiological Laboratory of the Medical School of Columbia University, New York, both in the fields of' carbon monoxide and shock. In 1946 he was offered the chairmanship of the Department of Colloid Science at Cambridge, which he only accepted after great hesitation, being worried by the title of the subject. In practice, however, it was interpreted as a mixture of surface chemistry and biophysical chemistry and these were, in fact,
DEDICATION
the general themes during Dr. Roughton1s 20 year tenure of the chair, from which he retired at the age limit in the fall of 1966.
Dr. Roughton1s researches during the past half-century have in general followed the initial 1921-1926 pattern of forming powerful and fairly lengthy partnerships, wherein he has had a substantial part to contribute. The early work on diffusion broadened to studies of mixed diffusion plus chemical reaction
processes, for example in analysing - both theoretically and experimentally - the factors determining the rate of penetration of oxygen and carbon monoxide into the red cell. This work has not only proved of importance to the detailed study of oxygen diffusion processes in the lung and the blood, but also has won for Dr. Roughton an important reputation in chemical engineering circles.
The rapid kinetic work, especially on the reactions of ligands with the heme groups in hemoglobin, has continued over the past 50 years, the last 20 of which have been occupied by a very fruitful, part-time partnership with Q. H. Gibson in this field. This work has won for him a still more prominent place in physical chemistry.
xiii
In 1931, stimulated by the revolutionary papers by Henriques from Copenhagen on the kinetics of the reactions of carbon dioxide in hemoglobin solution, Dr. Roughton began researches in this field, at first with Dr. R. Brinkman (of Holland) and Dr. R. Margaria (of Italy). In 1932 he succeeded, in brief partnership with an exceptionally gifted young biochemist, N. U. Meldrum, who died prematurely in the following year, in separating from blood highly concentrated and catalytically active solutions of the enzyme carbonic anhydrase, which now - just 40 years later - forms a complete section of the present conference.
Although Henriques in 1928 thought he had completely disproved the existence of an enzyme such as carbonic anhydrase in blood, he did however bring forward the first reliable evidence for a rapid, reversible, carbamate reaction of carbon dioxide with hemoglobin to form HbC02 . In 1933/1935 Ferguson and Roughton developed a difficult chemical method of estimating this compound, the role of which in the normal respiration-ci.rculation cycle was then evaluated. All this work was summarised in 1935 in a well-known article in Physiological Reviews entitled IIRecent Work on Carbon Dioxide Transport by the Blood l !.
Roughton continued researches both on carbonic anhydrase and on the carbamate problem intermittently during the next 25 years,
xiv DEDICATION
but it was not until his partnership with L. Rossi-Bernardi began in 1961 that he became deeply involved with HbC0 2 again. Some of the exciting results of this partnership are presented in this volume.
The interpretation of the kinetics of oxygen with hemoglobin requires a knowledge of the individual equilibrium constants of the 4-stage Adair reaction of oxygen with hemoglobin. During the past 25 years Dr. Roughton has, with 5 very able collaborators, succeeded in making specially accurate measurements both in the low range (0 to 1. 5% saturation) and the top range (98.5 to 100% saturation) of the oxygen dissociation curves of hemoglobin, and recently - in partnership with Dr. J. W. Severinghaus - of whole human blood under physiological conditions of CO pressure, pH, and temperature. By this work, and with genero~s assistance from statisticians and computers, he has succeeded to a reasonable extent in escaping from the impasse caused by four arbitrary constants in Adair's equation.
These six or seven lines of research in which Dr. Roughton has been a pioneer in the field of blood, physical chemistry and respiration, have brought him a number of honours. In his own country he was elected F. R. S. in 1936 and much more recently to honorary membership of the Physiological Society, to the Presidency of the Cambridge Philosophical Society (which publishes Biological Reviews) and to the F. G. Hopkins lectureship and medal, the highes t honor of the Biochemical Society. In the United States, where he has worked on and off for nearly 10 years of his life, he gave a HarveySociety lecture in 1943 (not knowing at the time of his relationship to William Harvey). He is an honorary member of the American Physiological Society and of the New York Academy of Sciences. In Denmark, where his work is also well-known and affectionately appreciated, in view of the great help he has derived and acknowledges from the class ical work of Carl Faurholt on carbamates, he is an honorary member of the Royal Academy of Letters and Sciences.
I am sad to report, that the day after this conference was over, Professor Roughton, who was unable to attend because of health problems, died in his horne of a cerebral hemorrhage.
L. Rossi-Bernardi Unive rs ity of Milan, Italy
CONTENTS
Participants . . . . . . . . . . . Registrants • . . . . . . . . . . . . . Abbreviations
I. HEMOGLOBIN STRUCTURE AND FUNCTION
Chairman: M. F. Perutz
Structure of Haemoglobin M Milwaukee, a Mutant Form Exhibiting Interaction between Ferrous
xxi
xxv
xxxi
and Ferric Subunits • • • • • • • • • • • • • •• 3 M. F. Perutz, 'R. D. Pulsinelli, and H. M. Ranney
The Interaction Between Hemoglobin and Its "Oxygen-Linked" Ligand s • • • • • • • • • • •
O. Brenna, M. Luzzana, M. Pace, M. Perrella, F. Rossi, L. Rossi-Bernardi, and F. J. W. Roughton
The Interaction of Sickle Hemoglobin with DPG, C02' and with Other Hemoglobins: Formation of Asyunnetrical Hybrids ••••••••••
H. Franklin Bunn
Enhancement of the Acid and Alkaline Bohr Effects of Hemoglobin by Organic Phosphates
A. Riggs and T. Imamura
Functional Non-Equivalence of a and ~ He~es in Human Hemoglobins • • • • • • . . . . . .
C. Ho and T. R. Lindstrom
xv
19
41
55
65
xvi CONTENTS
II. REIr CELL METABOLISM AND FUNCTION
Chairman: H. Franklin Bunn
Hemoglobin Ca sper G8 (3 106 Leu - Pro: Further Evidence that Hemoglobin Mutations are Not Random • • • • . • • • • •
R. T. Jones, R. D. Ko1er, M. Duerst, and Z. Stock1en
Potential Effects of Hemoglobin Concentration on Red Cell Metabolism Together with Observations on Red Cell Metabolic Differences Between Men and Women •
G. J. Brewer, F. J. Oe1sh1ege1, Jr., E. B. Schoomaker, and C. A. Knutsen
Catalase Activity and Red Cell Metabolism J. W. Eaton, M. Boraas, and N. L. Etkin
Red Cell Hexosemonophosphate Shunt Deficiency in Uremia .... . . . . . . . •
H. Jacob, Y. Yawata, and R. Howe
Effect of Inorganic Phosphate on Red Cell Metabolism: In Vitro and In Vivo Studies •• •••••
M. C. Brain and R. T. Card
Studies of the Metabolic Basis of the ATP-DPG Differences in Genetically Selected
79
99
121
133
145
High and Low ATP-DPG Rat Strains •••••••• 155 N. A. Noble and G. J. Brewer
III. CARBONIC ANHYDRASE AND CARBON DIOXIDE TRANSPORT
Chairman: Richard E. Tashian
Introductory Remarks at the Beginning of Session III R. E. Tashian
Functional Aspects of the Three-Dimensional Structure of the Active Site of Carbonic Anhydrase •••• • • • •
I. Waara, S. Lovgren, A. Li1jas, K. K. Kannan, and P.-C. Bergsten
The Effect of Temperature on the Catalytic Activity of Bovine Carbonic Anhydrase
J. C. Kernohan
167
169
189
CONTENTS
Carbonic Anhydrase, Red Cell Membranes, and C02 Transport • • • • • • . •
T. Enns
Effect of Ch1ortha1idone Binding on the Electrophoretic Properties of Human Red Cell Carbonic Anhydrase Isozymes
R. E. Tashian and Y.-S. L. Yu
The Role of Carbonic Anhydrase in the Control of Intracellular pH • • • •
W. J. Waddell
The Contribution of Carbamate in Human Adult and Foetal Blood to the C02 Exchange during the Respiratory Cycle • • . • • • • • •
C. Bauer
IV. SICKLE CELL STRUCTURE AND FUNCTION
Chairman: Donald L. Rucknage1
xvii
201
209
215
225
Introductory Remarks at the Beginning of Session IV • • •. 239 M. F. Perutz
Thermal (or Endothermic) Aggregation of Sickle Cell Hemoglobin (Hb S) During Sickling • • • •
M. Murayama
Chemical and Biological Aspects of the Inhibition of Red Blood Cell Sickling by Cyanate •
J. M. Manning, Ao Cerami, P. No Gillette, F. G. de Furia, and D. R. Miller
Preliminary Clinical Trials with Cyanate ••••• P. N. Gillette, C. M. Peterson, J. M. Manning, and A. Cerami
Carbamyl Phosphate Modification of Hemoglobin S Structure Resulting in Altered Sickling
L. M. Kraus, A. Rasad, and A. P. Kraus
Oxygen Affinity Independent Action of Cyanate and 2,3 DPG on Sickling •• ••••
M. C. Jensen, H. F. Bunn, G. C. Ha1ikas, and D. G. Nathan
Evaluation of Oral Urea in the Management of Sickle Cell Anemia ••••
J, Mo Lusher and M. I. Barnhart
243
253
261
279
297
303
xviii
The Sickling.Phenomenon of Deer Erythrocytes H. Kitchen and W. J. Taylor
. . . . . . . Further Studies on the Antenatal Detection of
Sickle Cell Anemia and Other Hemoglobinopathies ••••••••
H. H. Kazazian, Jr., M. M. Kaback, A. P. Woodhead, C. O. Leonard, and W. S. Nersesian
V. ADAPTA TION TO HYPOXIA
Chairman: Mikael Rorth
Adjustments of the Oxygen Transport System During Residence at High Altitude ••••••
L. H. Hartley
Red Cell Metabolism and Oxygen Affinity of Healthy
. . . . .
CONTENTS
325
337
349
Individuals during Exposure to High Altitude 361 M. Rorth, S. F. Nygaard, and H. H. Parving
Enzymatic Mechanisms of Red Cell Adaptation to Anemia 377 F. J. Oelshlegel, Jr., G. J. Brewer, J. A. Penner, and E. B. Schoomaker
Red Cell Metabolic Changes in Acute and Chronic Exposure to High Altitude •••• 397
L. G. Moore, G. J. Brewer, and F. J. Oe1sh1ege1, Jr.
Effects of Cyanate in Rabbits • D. R. Harkness, S .• Roth, P. Goldman, and M. Goldberg
VI. THE EFFECT OF OXYGEN AFFINITY ON
OXYGEN TRANSPORT: BLOOD STORAGE
Chairman: Stanley Ba1cerza~
Studies on the Ability of Stored Blood to Transport Oxygen In Vivo • • • • • • • • • • •
S. Balcerzak, J. Guy, E. Metz, and P. Bromberg
The Two Bohr Effects: Physiological Consequences of Ligand Interaction with Hemoglobin •
B. Wranne, R. Woodson, and J. Detter . . . . .
415
433
449
Rejuvenation and Freezing of Outdated Human Red Cells • •• 457 C. R. Valeri and C. G. Zarou1is
CONTENTS
Effects of Adenine on Stored Human Red Cells G, R. Bartlett
Hemoglobin Function During Blood Storage XV: Effects of Metabolic Additives Inosine and Methylene Blue on p50 and 2,3-DPG •••••
R. B. Dawson and W. F. Kocholaty
The Effect of Massive Transfusion of Stored Blood
xix
479
495
on Oxygen Transport - A Preliminary Report 511 S. V. Kevy, L, N. Button, and R, M. Filler
Index • . . . . . . . . . . • . . . . . . . . . . Q • • •• 517
PARTICIPANTS
Stanley P. Balcerzak, University Hospital, Columbus, Ohio
Grant Bartlett, Laboratory for Comparative Biochemistry, San Diego, California
Christian Bauer, Physiologisches Institut, Medizinische Hochschule, Roderbruchstrasse, Hanover, Ger.many
M. C. Brain, Department of Medicine, McMaster University Hamilton, Ontario, Canada.
George J. Brewer, Department of Human Genetics, University of Michigan, Ann Arbor, Michigan.
H. Franklin Bunn, Thorndike Memorial Laboratory, Harvard Medical School, Boston, Massachusetts.
James Manning, Rockefeller University, New York, N. Y.
R. Ben Dawson, School of Medicine, University of Maryland, Baltimore, Maryland 21201
John Eaton, Department of Anthropology, Washington Univers ity St. Louis, Missouri.
Theodore Enns, Scripps Institution of Oceanography, University of California, La Jolla, California.
Peter Gillette, Rockefeller University, New York, N. Y.
Donald Harkness, Veterans Administration Hospital, Miami, Florida.
L. Howard Hartley, Harvard Medical Unit, Boston City Hospital, Bos ton, Mas sachusetts.
Chien Ho, University of Pittsburgh, Department of Biophysics and Microbiology, Pittsburgh, Pennsylvania.
xxi
xxii PARTICIPANTS
Harry S. Jacob, Univers ity of Minnesota Medical School, Minneapolis, Minnesota.
Michael Jensen, The Children's Hospital Medical Center, Boston, Mas sachusetts.
Richard T. Jones, Department of Biochemistry, University of Oregon Medical School, Portland, Oregon.
Haig H. Kazazian, Jr., Johns Hopkins Hospital, Baltimore, Maryland.
John C. Kernohan, Biochemistry Department, The University of Dundee, Dundee, Scotland.
Sherwin V. Kevy, The Children's Hospital Medical Center, Bos ton, Mas sachusetts.
Hyram Kitchen, The Center for Laboratory Animal Resources, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan.
Lorraine Kraus, University of Tennessee Medical Units, Memphis, Tennessee.
Anders LUjas, Department of Biological Sciences, Purdue University, West Lafayette, Indiana.
Jeanne Lusher, Children's Hospital of Michigan, Detroit, Michigan.
Lorna Grindlay Moore, Department of Human Genetics, University of Michigan, Ann Arbor, Michigan.
Makio Murayama, National Institutes of Health, Bethesda, Maryland.
Nancy Noble, Department of Human Genetics, Univers ity. of Michigan, Ann Arbor, Michigan.
Fred J. Oelshlegel, Jr., Department of Human Genetics, University of Michigan, Ann Arbor, Michigan.
M. F. Perutz, MRC Laboratory of Molecular Biology, Hills Road, Cambridge, England.
Austen Riggs, Department of Zoology, University of Texas, Austin, Texas.
Mikael Rorth, Department of Clinical Chemistry, Rigshospitalet, Copenhagen, Denmark
PARTICIPANTS xxiii
L. Rossi-Bernardi, Universita Di Milano, Cattedra Di Enzimologia, Milano, Italy.
Donald L. Rucknagel, Department of Human Genetics, Univers ity of Michigan, Ann Arbor, Michigan.
Richard E. Tashian, Department of Human Genetics, University of Michigan, Ann Arbor, Michigan.
C. Robert Valeri, Naval Blood Research Laboratory, Chelsea, Mas sachusetts.
WilliaUl J. Waddell, Dental Research Center, Univers ity of North Carolina, Chapel Hill, North Carolina.
Robert D. Woodson, University Hospital, University of Washington, Seattle, Washington.
REGISTRANTS
Junius AdaITls, Veterans AdITlinistration West Side Hospital, Chicago, Illinois.
Clarence Alfrey, The Methodist Hospital, Houston, Texas.
Marion 1. Barnhart, Wayne State University School of Medicine, Detroit, Michigan.
Sandra Bittenbender, The Children1s Hospital Medical Center, Boston, Mas sachusetts.
John A. Black, University of Oregon Medical School, Portland, Oregon.
K. Boriboon, Children1 s Hospital of Michigan, Detroit, Michigan.
ThOITlas Bradley, Veterans AdITlinistration Hospital, San Francisco, California.
J. Phillip Brewer, Box 579, Greeley, Colorado.
Philip A. BroITlberg, Ohio State University Hospital, ColuITlbus, Ohio.
Lawrence Button, The Children1s Hospital Medical Center, Boston, Mas sachusetts.
David G. CaITleron, DepartITlent of Zoology, Montana State University, BozeITlan, Montana.
Donald C. CaITlpbell, Mayo Clinic, Rochester, Minnesota.
Robert T. Card, DepartITlent of Medicine, McMaster University, HaITlilton, Ontario, Canada.
Alfred Chanutin, BiocheITlical Laboratory, School of Medicine, University of Virginia, Charlottesville, Virginia.
SaITluel Charache, The Johns Hopkins Hospital, BaltiITlore, Maryland.
xxv
xxvi REGISTRANTS
Flossie Cohen, Children's Hospital of Michigan, Detroit, Michigan.
Melvin L. Conway, 600 E. Lafayette, Detroit, Michigan.
M. Robert Cooper, Bowman Gray School of Medicine, WinstonSalem, North Carolina.
Nannie K. M. de Leeuw, Royal Victoria Hospital, Montreal, Quebec, Canada.
Dennis A. Diederich, University of Kansas Medical Center, Kansas City, Kansas.
Gregory S. Duboff, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan
Miles J. Edwards, Department of Medicine, Univers ity of Oregon Medical School, Portland, Oregon.
Valerie Evans, Pontiac General Hospital, Department of 'Laboratories, Pontiac, Michigan.
Virgil F. Fairbanks, Mayo Clinic, Rochester, Minnesota.
C. Stephen Foster, National Institutes of Health, Bethesda, Maryland.
Milton H. Freedman, Baptist Profess ional Building, Atlanta, Georgia.
Gian F. Gaetani, Department of Pediatrics, University of North Carolina, School of Medicine, Chapel Hill, North Carolina,
Thomas A. Garrett, Travenol Laboratories, Inc., Morton Grove, Illinois.
Gary Geller, University of Minnesota, St. Paul, Minnesota.
Ronald O. Gilcher, Central Blood Bank of Pittsburgh, Pittsburgh, Pennsylvania.
John Gilman, 138 W. Gorham St., Madison, Wisconsin.
Owen C. Grush, Department of Pediatrics, Emory University Medical School, Atlanta, Georgia.
Jerry Guy, University Hospital, Columbus, Ohio.
Saburo Hara, Meharry Medical College, Nashville, Tennessee.
David J. Harris, Ecological Investigations Program, Center for Disease Control, Kansas City, Kansas.
REGISTRANTS xxvii
L. F. Hass, Department of Biological Chemistry, M. S. Hershey Medical Center, Hershey, Pennsylvania.
James A. Hogan, St. Barnabas Medical Center, Livingston, New Jersey.
Harold J. Hommerson, Butterworth Hospital, Grand Rapids, Michigan.
H. E. Hynes, Scott & White Clinic, Temple, Texas.
Takashi Imamura, Department of Zoology, University of Texas at Austin, Austin, Texas.
William Isaacs, Ibadan, Nigeria.
Rodger S. Izzo, Travenol Laboratories, Inc. Morton Grove, Illinois.
Rouben M. Jiji, University of Maryland Hospital, Baltimore, Maryland.
Violet Jiji, University of Maryland Hospital, Baltimore, Maryland.
Aaron M. Josephson, Travenol Laboratories, Inc. Morton Grove, Illinois
Yuet Wai Kan, The Children's Hospital Medical Center, Boston, Massachusetts.
Robert L. Kaufman, Department of Pediatrics, St. Louis Children's Hospital, St. Louis, Missouri.
Panpit P. Klug, Department of Medicine, George Washington University Medical Center, Washington, D. C.
Alfred P. Kraus, Section of Hematology, University of Tennessee, Memphis, Tennessee.
James E. Krook, Duke Hospital, Durham, North Carolina.
Wayne P. Krout, 440 New Castle Street, New Wilmington, Pennsylvania.
E. Stephen Kurtides, 3135 Park Place, Evanston, Illinois.
Lawrence S. Lessin, Department of Medicine, George Washington University Medical Center, Washington, D. C.
Michael Liepman, 2048 Charlton, Ann Arbor, Michigan.
Patrick C. McCarthy, Department of Biology, Westminister College, New Wilmington, Pennsylvania.
xxviii REGISTRANTS
Paul R. McCurdy, D. C. General Hospital, Washington, D. C.
Earl N. Metz, University Hospital, Columbus, Ohio.
Nydia Meyers, Department of Human Genetics, University of Michigan, Ann Arbor, Michigan.
Harry J. Miller, 2500 Ridge Avenue, Evanston, Illinois.
William W. Miller, Department of Pediatrics, University of Texas Southwestern Medical School, Dallas, Texas.
Paul F. Milner, The Johns Hopkins Hospital, Baltimore, Maryland.
Mary Jane Moore, Department of Anthropology, Univers ity of Wisconsin, Madison, Wisconsin.
Allan J. :Morris, Department of Biochemistry, Michigan State Univers ity, East Lansing, Michigan.
M. M. Mozen, Cutter Laboratories, Berkeley, California.
Stephen Murata, Medical World News, Chicago, Illinois.
James V. Neel, Department of Human Genetics, University of Michigan, Ann Arbor, Michigan
David J. Newman, Smith Kline & French Laboratories, Philadelphia, Pennsylvania.
Mohammed P. Nisar, Monmouth Medical Center, Long Branch, New Jersey.
James M. Norton, Research Department, Maine lv1edical Center, Portland, Maine.
Vasudeva Paniker, Divis ion of Hematology, Vanderbilt Univers ity, Nashville, Tennessee.
Philip Paress, Division of Hematology, Coney Island Hospital, Brooklyn, N. Y.
Catherine W. Patrick, Pontiac General Hospital, Department of Laboratories, Pontiac, Michigan.
Robert Peloquin, Institut D'Hematologie De Montreal, Montreal, P. Quebec, Canada.
Michele Perrella, Universita Di Milano, Cattedra Di Enzimologia, Milano, Italy.
David H. Petering, Department of Chemistry, University of Wisconsin, Milwaukee, Wisconsin.
REGISTRANTS
Robert M. Petitt, Mayo ClLnic, Rochester, Minnesota.
Peter W. Rand, Research Department, Maine Medical Center, Portland, Maine.
Y. Ravindranath, Children l s Hospital of Michigan, Detroit, Michigan.
xxix
1. Drummond Rennie, Presbyterian-St. Luke1s Hospital, Department of Medicine, Chicago, Illinois.
Richard Rice, Saint Vincent Hospital, Worcester, Massachusetts.
Robert D. Ringle, Ohio State University, Columbus, Ohio.
Julius Rutzky, William Beaumont Hospital, Royal Oak, Michigan.
Thomas H. Schmitz, Travenol Laboratories, Inc. Morton Grove, Illinois.
Joel M. Schwartz, Coney Island Hospital, Brooklyn, N. Y.
Ruth Andrea Seeler, Department of Pediatrics, Cook County Hospital, Chicago, Illinois.
George F. Sheldon, Department of Surgery, San Francisco General Hospital, San Francisco, California.
Charles E. Shields, Houston, Texas.
Gregory K. Snyder, Department of Medicine, University of Florida, Gainesville, Florida.
L. Michael Snyder, Saint Vincent Hospital, Worcester, Massachusetts.
Satish Srivastava, City of Hope Medical Center, Duarte, California.
James M. Stengle, National Institutes of Health, Bethesda, Maryland.
Ralph Stern, Carnegie Institution of Washington, Department of Embryology, Baltimore, Maryland.
Paul V. Strumia, Laboratory of Clinical Pathology, the Bryn Mawr Hospital, Bryn Mawr, Pennsylvania.
Kouichi R. Tanaka, Department of Medicine, Harbor General Hospital, Torrance, California.
xxx REGISTRANTS
Basil Tatsis, The Long Island Jewish Medical Center, Depart-ment of Hematology, Jamaica, New York.
Garson H. Tishkoff, American Red Cross, Lansing, Michigan.
Howard N. Ward, 204 Medical Arts Building, Topeka, Kansas.
Lowell Weitkamp, University of Rochester, Rochester, New York.
William L. White, 200 First St. S. W., Rochester, Minnesota.
John C. Wiltsie, Mayo Clinic, Rochester, Minnesota.
William P. Winter, Department of Human Genetics, University of Michigan, Ann Arbor, Michigan.
Alan Wright, AMA Audio News Journal, Chicago, Illinois.
Yoshihito Yawata, Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota.
Solomon J. Zak, Hematology Section, Veterans Administration Hospital, Minneapolis, Minnesota.
Alvin Zipursky, Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
Wolf W. Zuelzer, Children's Hospital of Michigan, Detroit, Michigan.
CO pCdZ co Hg IJ.M mM M gm % % 1J.1 ml L ACD CPD mole IJ.mole romole mg IJ.g g Kg m
em rom N hb hct rbc
ABBREVIA TrONS
oxygen oxygen pressure pressure of oxygen at which hemoglobin or red cells are half saturated with Oz carbon dioxide carbon dioxide pressure carbon monoxide mercury micromolar millimolar molar grams per 100 ml per cent microliter milliliter liter acid-citrate-dextrose preservative solution citrate-phosphate-dextrose preservative solution mole micromole millimole milligram microgram gram kilogram meters (for des ignating altitude) centimeter millimeter number in a sample hemoglobin hematocrit red blood cell
xxxi
xxxii
ATP,ADP, & AMP G-6-P NADP & NADPH GSSG & GSH G-6-PD 6-PG 6-PGD TK TA FDP DHAP GA-3-P NAD & NADH Pi 1,3-DPG 3-PG 2-PG DPG PEP PK LDH PGI PFK FA TPI
ABBREVIATIONS
adenos ine triphosphate, diphosphate and monophosphate, respecttvely
glucose 6 -phosphate oxidized and reduced nicotinamide adenine dinucleo
tide phosphate, respectively oxidized and reduced glutathione, respectively
glucose-6-phosphate dehydrogenase 6 -phosphogluconate 6-phosphogluconate dehydrogenase transketolase trans aldolase fructose-I, 6-diphosphate dihydroxyacetone phosphate glyceraldehyde 3-phosphate oxidized and reduced nicotinamide adenine dinucleotide, respectively inorganic phosphate 1,3-diphosphoglycerate 3-phosphoglycerate 2-phosphoglycerate 2,3-diphosphoglycerate phosphoenol pyruvate pyruvate kinase lactate dehydrogenase phosphoglucose isomerase phosphofructokinase fructoaldolase triosephosphate isomerase
GA-3-PD glyceraldehyde-3-phosphate dehydrogenase diphosphoglyce rate mutase 2, 3-diphosphoglycerate phosphatase 3-phosphoglycerate kinase
DPGM 2,3-DPGP 3-PGK PG-2, 3-M phosphoglycerate"-2, 3-mutase E PGM G-I-P G-l,6-DP F-6-p
enolase phosphoglucomutase glucose -l-phosphate glucose-l, 6-diphosphate fructose -6-phosphate